Warning: The NCBI web site requires JavaScript to function. more...
Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention.
Ethgen M, Boutron I, Steg PG, Roy C, Ravaud P.
Trials. 2009 May 4;10:29. Review.PMID: 19413903 [PubMed - indexed for MEDLINE]Related articlesFree article
Quality of reporting internal and external validity data from randomized controlled trials evaluating stents for percutaneous coronary intervention.
Ethgen M, Boutron L, Steg PG, Roy C, Ravaud P.
BMC Med Res Methodol. 2009 Apr 9;9:24.PMID: 19358717 [PubMed - indexed for MEDLINE]Related articlesFree article
Reporting of harm in randomized, controlled trials of nonpharmacologic treatment for rheumatic disease.
Ethgen M, Boutron I, Baron G, Giraudeau B, Sibilia J, Ravaud P.
Ann Intern Med. 2005 Jul 5;143(1):20-5.PMID: 15998751 [PubMed - indexed for MEDLINE]Related articlesFree article
Impact of medical practices on the costs of management of rheumatoid arthritis by anti-TNFalpha biological therapy in France.
Fautrel B, Woronoff-Lemsi MC, Ethgen M, Fein E, Monnet P, Sibilia J, Wendling D.
Joint Bone Spine. 2005 Dec;72(6):550-6.PMID: 15996504 [PubMed - indexed for MEDLINE]Related articles
Filter your results:
Trials. 2009 May 4; 10:29.
[Trials. 2009]
BMC Med Res Methodol. 2009 Apr 9; 9:24.
[BMC Med Res Methodol. 2009]
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...